Remedy for diagnostic of meningococcal infections - analogs
Pharmgroups: Immunobiological diagnostic tools |
|||||||||
Prices in pharmacies: Instructions Remedy for diagnostic of meningococcal infections | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Melaxen ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic neutral
- 40% Vaccine Meningococcal (groups A, C) polysaccharide prophylactica neutral
- 40% Vaccine Meningococcal (groups A, C, W, Y) polysaccharide prophylactica neutral
- 20% Vaccine meningococcae neutral
- 15% Remedy for diagnostic of tick-borne encephalitis neutral
- 14% Remedy for diagnostic of western American encephalomyelitis neutral
- 14% Remedy for diagnostic of Venezuelan encephalomyelitis neutral
- 14% Remedy for diagnostic of eastern American encephalomyelitis neutral
- 12% Rifampicin Negative 🔍
- 11% Interferon beta-1a neutral
- 10% Glatiramer acetate neutral
- 10% Ocrelizumab neutral
- 10% Peginterferon beta-1a neutral
- 10% Rotigotine neutral
- 10% Rivastigmin neutral
- 10% Natalizumab neutral
- 10% Tolcapone neutral
- 10% Laquinimod neutral
- 9% Rasagiline Negative 🔍
- 9% Tetrabenazine Negative 🔍
Learn more about the selection of analogues
- The drug has «Remedy for diagnostic of meningococcal infections» no complete analogues; 20 analogs by action, the most similar - Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic .
- Medical online service has selected the best substitutes for Remedy for diagnostic of meningococcal infections based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Remedy for diagnostic of meningococcal infections to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.